ADHD Clinical Trial
Official title:
The Feasibility of a Microbiome Dietary Intervention in Children With ADHD
Verified date | June 2019 |
Source | St Mary's University College |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim is to conduct a feasibility pilot study of a dietary intervention designed to optimise gut bacteria in children diagnosed with ADHD.
Status | Active, not recruiting |
Enrollment | 9 |
Est. completion date | July 2019 |
Est. primary completion date | July 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 8 Years to 13 Years |
Eligibility |
Inclusion Criteria: 1. Parent-reported diagnosis of ADHD. 2. Children aged between 8 years - 13 years 11 months at onset of study. 3. Children not taking ADHD medication (such as methylphenidate) at the time of the study. 4. Parental permission to attend three group sessions and for themselves and their child to complete the requisite assessments. 5. Both males and females are eligible to take part. 6. Children with a co-occurring diagnosis will be accepted onto the trial. 7. Children with food allergies/sensitivities/coeliac disease will be accepted onto the trial. Exclusion Criteria: 1. Children undergoing a current course of behavioural therapy. 2. Children currently on ADHD medication (such as methylphenidate). 3. Children who have taken antibiotics in the past 3 months |
Country | Name | City | State |
---|---|---|---|
United Kingdom | St Mary's University | London |
Lead Sponsor | Collaborator |
---|---|
St Mary's University College | Goldsmiths, University of London |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Completion of study | What proportion of participants completed the study? | final week | |
Secondary | Adherence to diet | Percentage adherence to diet over the 4-week period based on parental report (range 0-100 % - high score reflecting greater degree of adherence). | week 6 of diet | |
Secondary | Side-effects | Parent-reported side effects during course of study. (Qualitative) (More/more side-effects reflect poorer outcome). | duration of the 6 week diet | |
Secondary | The Conners Clinical Index (Conners CI) - Parent-report | Parental report of clinical symptoms (percentile score - higher score reflects more/more severe symptoms) Disruptive Behavior Indicator Learning and Language Disorder Indicator Mood Disorder Indicator Anxiety Disorder Indicator ADHD Indicator |
Baseline and week 6 of diet | |
Secondary | The Conners Clinical Index (Conners CI) - Teacher-report | Teacher report of clinical symptoms (percentile score - higher score reflects more/more severe symptoms) Disruptive Behavior Indicator Learning and Language Disorder Indicator Mood Disorder Indicator Anxiety Disorder Indicator ADHD Indicator |
Baseline and week 6 of diet | |
Secondary | The Conners Clinical Index (Conners CI) - Self-report | Child self-report of clinical symptoms (percentile score - higher score reflects more/more severe symptoms) Disruptive Behavior Indicator Learning and Language Disorder Indicator Mood Disorder Indicator Anxiety Disorder Indicator ADHD Indicator |
Baseline and week 6 of diet | |
Secondary | Delayed Match to Sample test (Cambridge Neuropsychological Test Automated Battery - CANTAB) Latency (response time) Accuracy (correct patterns selected). | Computerised test of visual working memory DMS Percent Correct (overall, for all delays, simultaneous, 0 sec delay, 4 sec delay, 12 sec delay). Range 0-100% - higher score reflects greater accuracy. DMS Mean & Median Correct Latency (overall, for all delays, simultaneous, 0 sec delay, 4 sec delay, 12 sec delay). Range 0-8 ms - higher score reflects worse performance. DMS Correct Latency Standard Deviation. Range 0-8 ms - higher score reflects worse performance. DMS Mean Choices to Correct response. Range 0-4 - higher score reflects worse performance. DMS Probability of Error Given Error. Range 0-1 - higher score reflects worse performance. |
Baseline and week 6 of diet | |
Secondary | The Consensus Sleep Diary | Record of sleep - used qualitatively to detect and remove artefacts from the data. | Baseline and week 6 of diet | |
Secondary | Children's Sleep Habits Questionnaire | Parental report of child's sleep A Total Sleep Disturbances score is calculated as the sum of all CSHQ scored questions, and can range from 33 to 99. A higher score indicates more problematic sleep. | Baseline and week 6 of diet | |
Secondary | Sleep self-report questionnaire | Week long retrospective sleep survey (Scores range from 13-39 with a higher score indicating more/more severe sleep difficulties). | Baseline and week 6 of diet | |
Secondary | Actigraphy recordings | Objective measure of sleep quality and daytime activity Mean activity during sleep. Range 0-8. A higher score = less sound sleep (worse). Minutes spent awake during the down period. Range 0-8. A higher score = less sound sleep (worse). Sleep latency (time taken to fall asleep). Range 0-8. A higher score = more time taken to fall asleep (worse). Sleep efficiency (% down period spent asleep, after removing sleep latency). A higher score = better. Wake after sleep onset (minutes spent awake during the down period after removing sleep latency). Range 0-8. A higher score = less sound sleep (worse). Sleep fragmentation (number of awakenings/ total minutes of sleep x 100) - Higher score = more fragmented sleep (worse). Mean daytime activity (0-8) not necessarily worse or better. |
Baseline and week 6 of diet | |
Secondary | The Gastrointestinal Symptom Rating | Questionnaire to evaluate common gastrointestinal symptoms Total scores range from 15-105 (with higher scores reflecting more/more severe gastrointestinal symptoms). Subscales: Abdominal pain (abdominal pain, hunger pains and nausea). Range 3-21 - a high score reflects worse symptoms. Reflux syndrome (heartburn and acid regurgitation). Range 3-21 - a high score reflects worse symptoms. Diarrhoea syndrome (diarrhoea, loose stools and urgent need for defecation). Range 3-21 - a high score reflects worse symptoms. Indigestion syndrome (borborygmus, abdominal distension, eructation and increased flatus). Range 3-21 - a high score reflects worse symptoms. Range 3-21 - a high score reflects worse symptoms. Constipation syndrome (constipation, hard stools and feeling of incomplete evacuation). Range 3-21 - a high score reflects worse symptoms. |
Baseline and week 6 of diet | |
Secondary | Stool sample analysis for commensal bacteria and microbial diversity using 16S rRNA sequencing | Analysis of bacterial strains and diversity within stool sample | Baseline and week 6 of diet | |
Secondary | Treatment Acceptability Scale | Questionnaire to assess the acceptability of the diet to parents of the children taking part in the study Score range 6-42 (High score reflects more positive attitude to treatment) | Baseline and week 6 of diet |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03148782 -
Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase
|
N/A | |
Recruiting |
NCT06038942 -
Formal Versus Informal Mindfulness Among University Students With Self-reported ADHD, Nonsuicidal Self-injury, or Stress
|
N/A | |
Not yet recruiting |
NCT06456372 -
Digital Health Intervention for Children With ADHD
|
N/A | |
Completed |
NCT05518435 -
Managing Young People With ADHD in Primary Care Study
|
||
Active, not recruiting |
NCT04978792 -
Does Cultivating Self-compassion Improve Resilience to Criticism and Improve Mental Health in Adults With ADHD?
|
N/A | |
Completed |
NCT03216512 -
Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD
|
N/A | |
Completed |
NCT02900144 -
Modified Comprehensive Behavioral Intervention for Tics (M_CBIT)
|
N/A | |
Not yet recruiting |
NCT02906501 -
Effect of Risperidone on Cognitive Functions in Adolescents With ADHD and Behavioral Disturbances
|
N/A | |
Completed |
NCT02829528 -
Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention
|
N/A | |
Completed |
NCT02562469 -
ACTIVATE: A Computerized Training Program for Children With ADHD
|
N/A | |
Terminated |
NCT02271880 -
Improving Medication Adherence in ADHD Adolescents
|
N/A | |
Recruiting |
NCT02255565 -
Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study
|
Phase 4 | |
Completed |
NCT02463396 -
Mindfulness Training in Adults With ADHD
|
N/A | |
Completed |
NCT01673594 -
Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist
|
Phase 4 | |
Terminated |
NCT01733680 -
Amiloride Hydrochloride as an Effective Treatment for ADHD
|
Early Phase 1 | |
Completed |
NCT02300597 -
Internet-based Support for Young People With ADHD and Autism - a Controlled Study
|
N/A | |
Active, not recruiting |
NCT01137318 -
Combined Cognitive Remediation and Behavioral Intervention for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)
|
Phase 2 | |
Completed |
NCT01404273 -
Functional MRI of Relaxation Response Training in Adults With Attention-Deficit/Hyperactivity Disorder
|
N/A | |
Completed |
NCT00586157 -
Study of Medication Patch to Treat Children Ages 6-12 With ADHD
|
Phase 4 | |
Completed |
NCT00573859 -
The Reinforcing Mechanisms of Smoking in Adult ADHD
|
Phase 1/Phase 2 |